Unicycive Therapeutics (UNCY) Earnings Date & Reports
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
UNCY is expected to report earnings to fall 88.30% to -7 cents per share on August 18
Q2'25
Est.
$-0.07
Q1'25
Missed
by $0.51
Q4'24
Beat
by $0.34
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.09
The last earnings report on May 14 showed earnings per share of -61 cents, missing the estimate of -10 cents. With 2.27M shares outstanding, the current market capitalization sits at 91.00M.